Carol L. Rosenberg

3.1k total citations
39 papers, 2.3k citations indexed

About

Carol L. Rosenberg is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Carol L. Rosenberg has authored 39 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 14 papers in Cancer Research and 13 papers in Pathology and Forensic Medicine. Recurrent topics in Carol L. Rosenberg's work include Breast Cancer Treatment Studies (10 papers), Genetic factors in colorectal cancer (7 papers) and BRCA gene mutations in cancer (5 papers). Carol L. Rosenberg is often cited by papers focused on Breast Cancer Treatment Studies (10 papers), Genetic factors in colorectal cancer (7 papers) and BRCA gene mutations in cancer (5 papers). Carol L. Rosenberg collaborates with scholars based in United States, Denmark and France. Carol L. Rosenberg's co-authors include Antonio de las Morenas, Andrew Arnold, A. Bale, Yuji Tsujimoto, Elizabeth M. Petty, Emily Wong, Nancy L. Harris, Andrew Arnold, M E Williams and S H Swerdlow and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Carol L. Rosenberg

38 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carol L. Rosenberg United States	26	1.1k	944	750	565	552	39	2.3k
Mogens Spang‐Thomsen Denmark	30	1.4k 1.3×	1.6k 1.7×	640 0.9×	292 0.5×	420 0.8×	96	3.0k
Rachel E. Ellsworth United States	25	720 0.7×	1.1k 1.1×	836 1.1×	224 0.4×	452 0.8×	91	2.2k
Rosemary L. Balleine Australia	23	791 0.7×	649 0.7×	481 0.6×	186 0.3×	680 1.2×	58	2.0k
Sten Wingren Sweden	24	1.0k 1.0×	701 0.7×	625 0.8×	443 0.8×	581 1.1×	63	2.1k
Barbara Hill United States	11	650 0.6×	1.4k 1.5×	1.1k 1.5×	273 0.5×	248 0.4×	16	2.4k
Maria Luisa Veronese United States	18	678 0.6×	969 1.0×	190 0.3×	262 0.5×	351 0.6×	35	1.8k
Iñigo Landa United States	24	983 0.9×	1.0k 1.1×	406 0.5×	363 0.6×	602 1.1×	46	3.0k
Dong‐Young Noh South Korea	31	853 0.8×	724 0.8×	928 1.2×	592 1.0×	329 0.6×	77	2.6k
Kaija Holli Finland	26	1.7k 1.6×	1.1k 1.2×	1.3k 1.7×	537 1.0×	1.3k 2.4×	54	3.3k
Melanie Royce United States	30	1.8k 1.7×	978 1.0×	1.2k 1.6×	364 0.6×	309 0.6×	93	3.1k

Countries citing papers authored by Carol L. Rosenberg

Since Specialization

Citations

This map shows the geographic impact of Carol L. Rosenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol L. Rosenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol L. Rosenberg more than expected).

Fields of papers citing papers by Carol L. Rosenberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol L. Rosenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol L. Rosenberg. The network helps show where Carol L. Rosenberg may publish in the future.

Co-authorship network of co-authors of Carol L. Rosenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Carol L. Rosenberg. A scholar is included among the top collaborators of Carol L. Rosenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol L. Rosenberg. Carol L. Rosenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fogh, Shannon, Ariel E. Hirsch, Saveli Goldberg, et al.. (2011). Use of Tamoxifen With Postsurgical Irradiation May Improve Survival in Estrogen and Progesterone Receptor–Positive Male Breast Cancer. Clinical Breast Cancer. 11(1). 39–45. 40 indexed citations

Rosenberg, Carol L.. (2011). Why Obama Can't Close Guantanamo. Foreign Affairs.

Hannafon, Bethany N., Paola Sebastiani, Antonio de las Morenas, Jining Lü, & Carol L. Rosenberg. (2011). Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer. Breast Cancer Research. 13(2). R24–R24. 146 indexed citations

Cronin‐Fenton, Deirdre, Thomas P. Ahern, Jens Peter Garne, et al.. (2011). Factors associated with concordant estrogen receptor expression at diagnosis and centralized re-assay in a Danish population-based breast cancer study. Acta Oncologica. 51(2). 254–261. 8 indexed citations

Graham, Kelly, Xijin Ge, Antonio de las Morenas, Anusri Tripathi�, & Carol L. Rosenberg. (2010). Gene Expression Profiles of Estrogen Receptor–Positive and Estrogen Receptor–Negative Breast Cancers Are Detectable in Histologically Normal Breast Epithelium. Clinical Cancer Research. 17(2). 236–246. 55 indexed citations

Chen, Yu, Xihua Wang, Mi K. Hong, et al.. (2010). Nanoelectronic detection of breast cancer biomarker. Applied Physics Letters. 97(23). 10 indexed citations

Lash, Timothy L., Deirdre Cronin‐Fenton, Thomas P. Ahern, et al.. (2010). Breast cancer recurrence risk related to concurrent use of SSRI antidepressants and tamoxifen. Acta Oncologica. 49(3). 305–312. 70 indexed citations

Morenas, Antonio de las, Anusri Tripathi�, Maureen Kavanah, et al.. (2010). Gene expression in histologically normal epithelium from breast cancer patients and from cancer-free prophylactic mastectomy patients shares a similar profile. British Journal of Cancer. 102(8). 1284–1293. 75 indexed citations

Lash, Timothy L., Jennifer Westrup, Marjory Charlot, et al.. (2009). Triple-negative breast cancers are increased in black women regardless of age or body mass index. Breast Cancer Research. 11(2). R18–R18. 202 indexed citations

10.

Schlechter, Benjamin L., et al.. (2008). CDKN1C/p57kip2is a candidate tumor suppressor gene in human breast cancer. BMC Cancer. 8(1). 68–68. 46 indexed citations

11.

Lash, Timothy L., Lars Pedersen, Deirdre Cronin‐Fenton, et al.. (2008). Tamoxifen's protection against breast cancer recurrence is not reduced by concurrent use of the SSRI citalopram. British Journal of Cancer. 99(4). 616–621. 48 indexed citations

12.

Rosenberg, Carol L., et al.. (2007). Safe Administration of Iron Sucrose in a Patient with a Previous Hypersensitivity Reaction to Ferric Gluconate. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 27(4). 613–615. 6 indexed citations

13.

Morenas, Antonio de las, et al.. (2006). In utero exposure to diethylstilbestrol (DES) does not increase genomic instability in normal or neoplastic breast epithelium. Cancer. 107(9). 2122–2126. 9 indexed citations

14.

Guo, Ning, et al.. (2005). Reliability and Reproducibility of Gene Expression Measurements Using Amplified RNA from Laser-Microdissected Primary Breast Tissue with Oligonucleotide Arrays. Journal of Molecular Diagnostics. 7(1). 57–64. 45 indexed citations

15.

Morenas, Antonio de las, et al.. (2002). Loss of Heterozygosity or Allele Imbalance in Histologically Normal Breast Epithelium Is Distinct from Loss of Heterozygosity or Allele Imbalance in Co-Existing Carcinomas. American Journal Of Pathology. 161(1). 283–290. 58 indexed citations

16.

Palmer, Julie R., Elizabeth E. Hatch, Carol L. Rosenberg, et al.. (2002). Risk of breast cancer in women exposed to diethylstilbestrol in utero: preliminary results (United States). Cancer Causes & Control. 13(8). 753–758. 115 indexed citations

17.

Rosenberg, Carol L., et al.. (2000). DNA alterations in tumor scrapesvs. biopsies of squamous-cell carcinomas of the head and neck. International Journal of Cancer. 89(2). 105–110. 3 indexed citations

18.

Morenas, Antonio de las, et al.. (1998). Genetically abnormal clones in histologically normal breast tissue.. PubMed. 152(6). 1591–8. 79 indexed citations

19.

Williams, M E, S H Swerdlow, Carol L. Rosenberg, & Andrew Arnold. (1993). Chromosome 11 translocation breakpoints at the PRAD1/cyclin D1 gene locus in centrocytic lymphoma.. PubMed. 7(2). 241–5. 92 indexed citations

20.

Williams, Michael E., Steven H. Swerdlow, Carol L. Rosenberg, & Andrew Arnold. (1992). Centrocytic Lymphoma: a B-Cell Non-Hodgkin’s Lymphoma Characterized by Chromosome 11 BCL-1 and PRAD 1 Rearrangements. Current topics in microbiology and immunology. 182. 325–329. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact